1. Potential for cell therapy in Parkinson׳s disease using genetically programmed human embryonic stem cell-derived neural progenitor cells;Ambasudhan;J. Comp. Neurol.,2014
2. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain;Andres;Brain,2011
3. In vitro and in vivo differentiation of boundary cap neural crest stem cells into mature Schwann cells;Aquino;Exp. Neurol.,2006
4. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats;Aubry;Proc. Natl. Acad. Sci. USA,2008
5. Bar-Or A. Boivin M.-N., Rozenberg A., Johnson T., Belabani C., Morisse G., Sirois J., Lai Wing Sun S., Vanamala S., Del Rosario Villalobos A., Reese Koc J., Morrison S., Bermel R.A., Imrey P.B., Planchon S.M., Cohen J.A., 2014. Immune function monitoring in a phase I trial of autologous culture-expanded mesenchymal stem cell transplantation for relapsing multiple sclerosis. European Committee for Treatment and Research in Multiple Sclerosis Meeting. Boston, MA.